Karyopharm Therapeutics | KPTI - Ordinary Share Capital

Stock Price
5.21
Daily Change
-0.24 -4.32%
Monthly
-44.33%
Yearly
7.32%
Q1 Forecast
7.40

Karyopharm Therapeutics reported $13K in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 23.39B Sep/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Enanta Pharmaceuticals USD 212K 1000 Dec/2023
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
J&J USD 2.41B 584K Sep/2025
Karyopharm Therapeutics USD 13K 0 Sep/2024
MacroGenics USD 63.32M 60K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Novartis USD 1.91B 10.64M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Takeda JPY 1.58B 2K Dec/2025
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Xencor USD 71.87M 529K Dec/2025